Hongchuan Liu

机构：Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University · ORCID：0000-0001-8732-7812

发表论文 56 篇 · 总被引 872 次 · h-index 15

代表论文

• Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8+ T cells and the exclusion of Treg cells (2022 · Frontiers in Immunology · 被引 61)
• Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants (2022 · Emerging Microbes & Infections · 被引 18)
• Determination of boiling point distribution by TG using a novel crucible and comparison with true boiling point distillation and simulated distillation by GC–MS and Py-GC/MS (2024 · Chemical Engineering Journal · 被引 6)
• Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation (2024 · Rapid Communications in Mass Spectrometry · 被引 5)
• Machine learning reveals serum myristic acid, palmitic acid and heptanoylcarnitine as biomarkers of coronary artery disease risk in patients with type 2 diabetes mellitus (2024 · Clinica Chimica Acta · 被引 5)
• Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21 (2023 · Journal of drug targeting · 被引 4)